|
1
|
Shim M, Song C, Park S, Choi SK, Cho YM,
Kim CS and Ahn H: Prognostic significance of platelet-derived
growth factor receptor-β expression in localized clear cell renal
cell carcinoma. J Cancer Res Clin Oncol. 141:2213–2220. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rini BI, Campbell SC and Escudier B: Renal
cell carcinoma. Lancet. 373:1119–1132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Widodo, Djati MS and Rifa’i M: Role of
MicroRNAs in carcinogenesis that potential for biomarker of
endometrial cancer. Ann Med Surg (Lond). 7:9–13. 2016. View Article : Google Scholar :
|
|
4
|
Murugan AK, Munirajan AK and Alzahrani AS:
MicroRNAs: modulators of the Ras oncogenes in oral cancer. J Cell
Physiol. 231:1424–1431. 2016. View Article : Google Scholar
|
|
5
|
Yu X and Li Z: The role of microRNAs
expression in laryngeal cancer. Oncotarget. 6:23297–23305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SH, Jung YD, Choi YS and Lee YM:
Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases
cell proliferation and tumor angiogenesis in gastric cancer cells.
Oncotarget. 6:33269–33278. 2015.PubMed/NCBI
|
|
7
|
Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q,
Park SJ, Shin WC, Yang HD, Park M, Park WS, et al: MicroRNA-31
functions as a tumor suppressor by regulating cell cycle and
epithelial-mesenchymal transition regulatory proteins in liver
cancer. Oncotarget. 6:8089–8102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Wang Y, Sun X, Mei C, Wang L, Li Z
and Zha X: miR-449a promotes liver cancer cell apoptosis by
downregulation of Calpain 6 and POU2F1. Oncotarget. 7:13491–13501.
2016.
|
|
9
|
Croce C: Introduction to the role of
microRNAs in cancer diagnosis, prognosis, and treatment. Cancer J.
18:213–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xing T and He H: Epigenomics of clear cell
renal cell carcinoma: Mechanisms and potential use in molecular
pathology. Chin J Cancer Res. 28:80–91. 2016.PubMed/NCBI
|
|
11
|
White NM, Bao TT, Grigull J, Youssef YM,
Girgis A, Diamandis M, Fatoohi E, Metias M, Honey RJ, Stewart R, et
al: miRNA profiling for clear cell renal cell carcinoma: Biomarker
discovery and identification of potential controls and consequences
of miRNA dysregulation. J Urol. 186:1077–1083. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tang K and Xu H: Prognostic value of
meta-signature miRNAs in renal cell carcinoma: An integrated miRNA
expression profiling analysis. Sci Rep. 5:102722015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Osanto S, Qin Y, Buermans HP, Berkers J,
Lerut E, Goeman JJ and van Poppel H: Genome-wide microRNA
expression analysis of clear cell renal cell carcinoma by next
generation deep sequencing. PLoS One. 7:e382982012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
White NM, Khella HW, Grigull J, Adzovic S,
Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA,
et al: miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yue H, Yang BO, Yang F, Hu XL and Kong FB:
Co-expression network-based analysis of hippocampal expression data
associated with Alzheimer’s disease using a novel algorithm. Exp
Ther Med. 11:1707–1715. 2016.PubMed/NCBI
|
|
16
|
Feitelson MA, Arzumanyan A, Kulathinal RJ,
Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML,
Nawroth R, Sanchez-Garcia I, et al: Sustained proliferation in
cancer: Mechanisms and novel therapeutic targets. Semin Cancer
Biol. 35(Suppl): 1707–1715. 2015. View Article : Google Scholar
|
|
17
|
Yang Q, Lin H, Wu S, Lei F, Zhu X, Song L,
Hong M and Guo L: Prostate tumor overexpressed 1 (PTOV1) is a novel
prognostic marker for nasopharyngeal carcinoma progression and poor
survival outcomes. PLoS One. 10:e01364482015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamada N, Tsujimura N, Kumazaki M,
Shinohara H, Taniguchi K, Nakagawa Y, Naoe T and Akao Y: Colorectal
cancer cell-derived microvesicles containing microRNA-1246 promote
angiogenesis by activating Smad 1/5/8 signaling elicited by PML
down-regulation in endothelial cells. Biochim Biophys Acta.
1839:1256–1272. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen W, Zhou S, Mao L, Zhang H, Sun D,
Zhang J, Li J and Tang JH: Crosstalk between TGF-β signaling and
miRNAs in breast cancer metastasis. Tumour Biol. 37:10011–10019.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Preusse M, Theis FJ and Mueller NS:
miTALOS v2: Analyzing tissue specific microRNA function. PLoS One.
11:e01517712016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Du X, Wei S, Li D and Li Q: A
comprehensive transcriptomic view on the role of SMAD4 gene by
RNAi-mediated knockdown in porcine follicular granulosa cells.
Reproduction. 152:81–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen J, Yan D, Wu W, Zhu J, Ye W and Shu
Q: MicroRNA-130a promotes the metastasis and epithelial-mesenchymal
transition of osteosarcoma by targeting PTEN. Oncol Rep.
35:3285–3292. 2016.PubMed/NCBI
|
|
23
|
Lee CC, Yang WH, Li CH, Cheng YW, Tsai CH
and Kang JJ: Ligand independent aryl hydrocarbon receptor inhibits
lung cancer cell invasion by degradation of Smad4. Cancer Lett.
376:211–217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu ZH, Tao ZH, Zhang J, Li T, Ni C, Xie J,
Zhang JF and Hu XC: MiRNA-21 induces epithelial to mesenchymal
transition and gemcitabine resistance via the PTEN/AKT pathway in
breast cancer. Tumour Biol. 37:7245–7254. 2016. View Article : Google Scholar
|
|
25
|
Marioni G, Agostini M, Cappellesso R,
Bedin C, Ottaviano G, Marchese-Ragona R, Lovato A, Cacco T,
Giacomelli L, Nitti D, et al: miR-19a and SOCS-1 expression in the
differential diagnosis of laryngeal (glottic) verrucous squamous
cell carcinoma. J Clin Pathol. 69:415–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Yang S, Yan W, Yang J, Qin YJ, Lin
XL, Xie RY, Wang SC, Jin W, Gao F, et al: MicroRNA-19 triggers
epithelial-mesenchymal transition of lung cancer cells accompanied
by growth inhibition. Lab Invest. 95:1056–1070. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin S, Ai F, Ji WF, Rao W, Zhang HC and
Yao WJ: miR-19a promotes cell growth and tumorigenesis through
targeting SOCS1 in gastric cancer. Asian Pac J Cancer Prev.
14:835–840. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Baik SH, Lee J, Lee YS, Jang JY and Kim
CW: ANT2 shRNA downregulates miR-19a and miR-96 through the
PI3K/Akt pathway and suppresses tumor growth in hepatocellular
carcinoma cells. Exp Mol Med. 48:e2222016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang F, Wang H, Jiang Z, Hu A, Chu L, Sun
Y and Han J: MicroRNA-19a mediates gastric carcinoma cell
proliferation through the activation of nuclear factor-κB. Mol Med
Rep. 12:5780–5786. 2015.PubMed/NCBI
|
|
30
|
Li HW, Xie Y, Li F, Sun GC, Chen Z and
Zeng HS: Effect of miR-19a and miR-21 on the JAK/STAT signaling
pathway in the peripheral blood mononuclear cells of patients with
systemic juvenile idiopathic arthritis. Exp Ther Med. 11:2531–2536.
2016.PubMed/NCBI
|
|
31
|
Xie CY, Kong JR, Zhao CS, Xiao YC, Peng T,
Liu Y and Wang WN: Molecular characterization and function of a
PTEN gene from Litopenaeus vannamei after Vibrio alginolyticus
challenge. Dev Comp Immunol. 59:77–88. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xiao W, Gao Z, Duan Y, Yuan W and Ke Y:
Downregulation of miR-19a exhibits inhibitory effects on metastatic
renal cell carcinoma by targeting PIK3CA and inactivating Notch
signaling in vitro. Oncol Rep. 34:739–746. 2015.PubMed/NCBI
|
